Search
for
Sort by
Research 31–60 of 918
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Low leptin level in an obese hyperandrogenic woman – potential marker for androgen-secreting tumor
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Reconsidering the Polycystic Ovary Syndrome (PCOS)
- Frontal fibrosing alopecia: A new autoimmune entity?
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- PLASMA UNBOUND AND UNCONJUGATED ANDROGENS IN ORIENTAL MEN
- Evaluation of Low Testesterone Levels in Male Dogs with Alopecia
- Foreword
- Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
- Bioavailability of Albumin-Bound Testosterone†
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis
- Cardiovascular risk factors and events in women with androgen excess
- Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Alterations in androgen conjugate levels in women and men with alopecia
- Current Aspects of Antiandrogen Therapy in Women
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Idiopathic hirsutism: Is it really idiopathic or is it misnomer?